Ventana Medical Systems, Inc. (VMSI) and BioCare Medical Sign Agreement
2/27/2013 9:09:49 AM
More...
|
MolecularMD and Ventana Medical Systems, Inc. (VMSI) Reach Collaborative Research Agreement: Limits of Detection and Sensitivity for PTEN Gene Using In-Situ Hybridization and Immunohistochemistry Methods
12/6/2012 10:03:55 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) CEO Headlines Congressional Briefing on Patient Safety and Cancer
11/20/2012 9:44:57 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) Scientists to Reveal Latest Advancements in Multiplexing Gene and Protein Targets for Personalized Medicine and Breast Cancer Testing at Pathology Visions 2012
10/23/2012 12:11:57 PM
More...
|
Ventana Medical Systems, Inc. (VMSI) Unveils the Latest in Digital Pathology and Lab Workflow Solutions at IAP 2012 in Cape Town
9/27/2012 10:18:16 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) Develops First-Ever Fully Automated Dual-Stain Technique for Mirna and Protein Detection in Cancer
9/7/2012 10:41:21 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) Supports World Patient Safety Day, July 25
7/18/2012 11:07:59 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) Takes Digital Pathology to a New Level with the New VENTANA iScan HT Scanner
6/13/2012 10:39:24 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) Signs Exclusive Licensing Agreement for the Commercialization of a Novel BRAF V600E Mutation Antibody for Cancer Detection
5/31/2012 12:43:10 PM
More...
|
Ventana Medical Systems, Inc. (VMSI) Licenses Gen-Probe Incorporated (GPRO) IP for Measuring ERG Protein in Prostate Cancer Patients
5/21/2012 11:44:40 AM
More...
|
|